Skip to search formSkip to main contentSkip to account menu

Instanyl

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Von Anfang an den Darm in Schwung bringen!
Durchbruchschmerzen (DBS) überfallen Tumorschmerzpatienten meist wie aus heiterem Himmel und entwickeln ihre maximale Stärke… 
2015
2015
Gasto económico del tratamiento del dolor irruptivo
2014
2014
Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS)
Objective: Breakthrough cancer pain (BTcP) affects 19-95% of cancer patients (dependent on the definition and methods used and… 
2013
2013
Letter to the Editor: Trauma pain – a military perspective
We read with interest the article on the military perspective of trauma pain.1 We agree that the dose and the intramuscular route… 
2013
2013
An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
BACKGROUND Intranasal Fentanyl Spray (INFS) was developed for the treatment of breakthrough pain (BTP) in cancer patients using a… 
2013
2013
Long term observation of patient using Instanyl for breakthrough pain treatment during advanced neoplastic process
The case study presents a 75-year-old female patient treated at the Outpatient Clinic Prosen. The patient with advanced cancer… 
2013
2013
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP)
Background: Breakthrough cancer pain (BTcP) is a transitory exacerbation of the intensity of the pain in a patient with… 
2012
2012
Mise au point sur l’utilisation du fentanyl transmuqueux chez le patient présentant des douleurs d’origine cancéreuse
2012
2012
Single-dose and multi-dose delivery systems for intranasal fentanyl spray are bioequivalent as demonstrated in a replicate pharmacokinetic study.
BACKGROUND Intranasal fentanyl spray (INFS, Instanyl®) was developed to treat cancer patients with Breakthrough Pain (BTP). INFS… 
Review
2011
Review
2011
Newer Generation Fentanyl Transmucosal Products for Breakthrough Pain in Opioid-Tolerant Cancer Patients
Oral normal-release morphine has long been considered the gold-standard treatment for cancer breakthrough pain. However, its… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)